Study demonstrates clinical and cost effectiveness of Rogers PHP and IOP continuum03/21/18 02:12:pm
A cost-benefit analysis for OCD treatment conducted by Dr. Brad Riemann, Brian Kay, and two professors has been published in the Journal of Clinical Psychiatry.
The study compared the outcomes and costs of seven empirically-based treatment strategies including:
- Antidepressant medication only
- Antidepressant medication and antipsychotic
- Antidepressant medication and CBT delivered one to one by a psychologist
- Combination of medications and CBT in PHP
- IOP only
- PHP only
- Combination of medications and PHP stepping down to IOP
The data analyzed included patient-reported outcome measures at admission, discharge, and one year after care as well as total charges for the care provided.
Results showed that the treatment with the highest benefit (best clinical outcomes and most cost effective) was the option of PHP stepping down to IOP. Of the seven treatment strategies analyzed, four used data from Rogers programs. The results validated that patients benefit from the outpatient continuum of care that Rogers offers.
“This study provides us with some very important findings. Specifically, someone following a continuum of care from partial hospitalization to intensive outpatient not only does better in the short run but also in the long run over the course of a lifespan when compared to other powerful treatments. The study also produced evidence that following this continuum provides significant health care cost savings,” comments Dr. Brad Riemann, PhD, chief clinical officer and study co-author.